{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:20:49Z","timestamp":1776730849398,"version":"3.51.2"},"reference-count":33,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2011,5,11]],"date-time":"2011-05-11T00:00:00Z","timestamp":1305072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>The present study was aimed at assessing quality of life (QoL) in a total of 450 melanoma patients who filled out the EORTC QLQ-C30 (Q1; 15 months post diagnosis) as part of the OVIS Study. Follow-up questionnaires (Q2) were administered two years after Q1. The analyses presented herein were based on the following assumptions: QoL of melanoma patients is worse than that of a German reference population. Further, both tumor location and tumor stage have an influence on self-reported QoL, with patients with tumors located on face, head, neck, and advanced tumor stage (T3\/T4) reporting the worst QoL levels. Finally, patients\u2019 QoL improves over time based on the theory of disease adaptation. In contrast to the above assumptions, with the exception of global health\/QoL scores, differences between OVIS and the reference population were below the minimal clinical important difference of ten points. Furthermore, no clinically meaningful differences were found between patients after stratifying our data by tumor location and tumor stage. Finally, no clinically relevant changes were seen between Q1 and Q2 across all scales of the EORTC QLQ-C30. However, when data were stratified by patients with stable disease versus those with progression, clinically relevant differences were found between Q1 and Q2 predominantly in women in the latter group regarding emotional function, insomnia, dyspnoea, and fatigue. The lack of clinically meaningful differences across strata (tumor location; tumor stage), time, and patients compared to a reference population is surprising. However, it is possible that the instrument used, a generic QoL instrument, is generally not sensitive enough to detect differences in melanoma patients. Our findings may further be explained by the fact that all patients included in our sample had been diagnosed well before Q1, i.e., main illness adaptation processes may have occurred before study entry.<\/jats:p>","DOI":"10.3390\/cancers3022316","type":"journal-article","created":{"date-parts":[[2011,5,11]],"date-time":"2011-05-11T11:10:03Z","timestamp":1305112203000},"page":"2316-2332","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Different Aspects of Self-Reported Quality of Life in 450 German Melanoma Survivors"],"prefix":"10.3390","volume":"3","author":[{"given":"Annika","family":"Waldmann","sequence":"first","affiliation":[{"name":"Institute of Cancer Epidemiology (IKE e.V.), University of Luebeck, Ratzeburger Allee 160 (Haus 50), Luebeck 23562, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Nolte","sequence":"additional","affiliation":[{"name":"Association of Dermatological Prevention (ADP e.V.), Cremon 11, Hamburg 20457, Germany"},{"name":"Deakin University, 221 Burwood Highway, Burwood, VIC 3125, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Pritzkuleit","sequence":"additional","affiliation":[{"name":"Institute of Cancer Epidemiology (IKE e.V.), University of Luebeck, Ratzeburger Allee 160 (Haus 50), Luebeck 23562, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eckhard W.","family":"Breitbart","sequence":"additional","affiliation":[{"name":"Association of Dermatological Prevention (ADP e.V.), Cremon 11, Hamburg 20457, Germany"},{"name":"Center of Dermatology, Am Krankenhaus 1, Buxtehude 21614, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Katalinic","sequence":"additional","affiliation":[{"name":"Institute of Cancer Epidemiology (IKE e.V.), University of Luebeck, Ratzeburger Allee 160 (Haus 50), Luebeck 23562, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2011,5,11]]},"reference":[{"key":"ref_1","unstructured":"Husmann, G., Kaatsch, P., Katalinic, A., Bertz, J., Kraywinkel, K., and Ute, W. (2010). Krebs in Deutschland 2005\/2006 H\u00e4ufigkeiten und Trends. Beitr\u00e4ge zur Gesundheitsberichterstattungdes Bundes, 52\u201355."},{"key":"ref_2","unstructured":"IARC GLOBOCAN 2008 FAST STATS: Germany Home Page. Available online: http:\/\/globocan.iarc.fr\/factsheets\/populations\/factsheet.asp?uno=276\/ (accessed 12 July 2010)."},{"key":"ref_3","unstructured":"IARC GLOBOCAN 2008 FAST STATS: Australia\/New Zealand Home Page. Available online: http:\/\/globocan.iarc.fr\/factsheets\/populations\/factsheet.asp?uno=927\/ (accessed 12 July 2010)."},{"key":"ref_4","unstructured":"IARC GLOBOCAN 2008 FAST STATS: Less developed regions Home Page. Available online: http:\/\/globocan.iarc.fr\/factsheets\/populations\/factsheet.asp?uno=902\/ (accessed 12 July 2010)."},{"key":"ref_5","unstructured":"Tumorregister M\u00fcnchen \u00dcberleben C43: Malignes Melanom Home Page. Avaailable online: http:\/\/www.tumorregister-muenchen.de\/facts\/surv\/surv_C43__G.pdf (accessed 12 July 2010)."},{"key":"ref_6","unstructured":"Garbe, C., Hauschild, A., Volkenandt, M., Schadendorf, D., Stolz, W., Kortmann, R., Kettelhack, C., Frerich, B., Keilholz, U., and Dummer, R. Deutsche Leitlinie: Malignes Melanom. Available online: http:\/\/www.ado-homepage.de\/projekte\/1\/upload\/leitlinie_melanom_ado_2005.pdf (accessed on 11 May 2011)."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1524-4725.1993.tb00369.x","article-title":"Melanoma update. Second primary melanoma","volume":"19","author":"Frank","year":"1993","journal-title":"J. Dermatol. Surg. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1067\/mjd.2001.110878","article-title":"Multiple primary melanomas","volume":"44","author":"Scheffer","year":"2001","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1046\/j.1365-2133.2002.48893.x","article-title":"Patients' perception of the cause of their melanoma differs from that of epidemiologists","volume":"147","author":"Dore","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"vi51","DOI":"10.1093\/annonc\/mdp255","article-title":"A systematic review of health-related quality of life in cutaneous melanoma","volume":"20","author":"Cornish","year":"2009","journal-title":"Ann. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/archdermatol.2010.433","article-title":"Impact of melanoma on patients' lives among 562 survivors: A dutch population-based study","volume":"147","author":"Holterhues","year":"2011","journal-title":"Arch. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/1471-2407-8-311","article-title":"The population-based oncological health care study OVIS\u2014Recruitment of the patients and analysis of the non-participants","volume":"8","author":"Pritzkuleit","year":"2008","journal-title":"BMC Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1002\/1097-0142(19950515)75:10<2492::AID-CNCR2820751015>3.0.CO;2-W","article-title":"Primary cutaneous melanoma. Prognostic classification of anatomic location","volume":"75","author":"Garbe","year":"1995","journal-title":"Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1001\/archderm.144.4.515","article-title":"Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program","volume":"144","author":"Lachiewicz","year":"2008","journal-title":"Arch. Dermatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/cncr.20816","article-title":"Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society","volume":"103","author":"Buettner","year":"2005","journal-title":"Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archotol.133.5.442","article-title":"Epidemiological features and prognostic factors of cutaneous head and neck melanoma: A population-based study","volume":"133","author":"Golger","year":"2007","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0959-8049(98)00136-1","article-title":"Using reference data on quality of life\u2014The importance of adjusting for age and gender, exemplified by the EORTC QLQ-C30 (+3)","volume":"34","author":"Hjermstad","year":"1998","journal-title":"Eur. J. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1245\/s10434-009-0602-6","article-title":"Quality of life after axillary or groin sentinel lymph node biopsy, with or without completion lymph node dissection, in patients with cutaneous melanoma","volume":"16","author":"Hoekstra","year":"2009","journal-title":"Ann. Surg. Oncol."},{"key":"ref_19","first-page":"139","article-title":"Measuring quality of life in patients with melanoma: Development of the FACT-melanoma subscale","volume":"3","author":"Cormier","year":"2005","journal-title":"J. Support. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1002\/cncr.23424","article-title":"Prospective assessment of the reliability, validity, and sensitivity to change of the Functional Assessment of Cancer Therapy-Melanoma questionnaire","volume":"112","author":"Cormier","year":"2008","journal-title":"Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1037\/0021-9010.64.2.144","article-title":"Response-shift bias: A source of contamination of self-report measures","volume":"64","author":"Howard","year":"1979","journal-title":"J. Appl. Psychol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0277-9536(99)00045-3","article-title":"Integrating response shift into health-related quality of life research: A theoretical model","volume":"48","author":"Sprangers","year":"1999","journal-title":"Soc. Sci. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s11136-006-0025-9","article-title":"The clinical significance of adaptation to changing health: A meta-analysis of response shift","volume":"15","author":"Schwartz","year":"2006","journal-title":"Qual. Life Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s11136-006-9161-5","article-title":"The OVIS study: Health related quality of life measured by the EORTC QLQ-C30 and -BR23 in German female patients with breast cancer from Schleswig-Holstein","volume":"16","author":"Waldmann","year":"2007","journal-title":"Qual. Life Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/1471-2407-9-295","article-title":"Measuring prostate-specific quality of life in prostate cancer patients scheduled for radiotherapy or radical prostatectomy and reference men in Germany and Canada using the Patient Oriented Prostate Utility Scale-Psychometric (PORPUS-P)","volume":"9","author":"Waldmann","year":"2009","journal-title":"BMC Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1464-410X.2006.06128.x","article-title":"Health-related quality of life and satisfaction with care among older men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy","volume":"97","author":"Jayadevappa","year":"2006","journal-title":"BJU Int."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/pcan.2009.32","article-title":"Utility and health-related quality of life in prostate cancer patients 12 months after radical prostatectomy or radiation therapy","volume":"12","author":"Krahn","year":"2009","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/annonc\/mdi146","article-title":"Predictors of quality of life in newly diagnosed melanoma and breast cancer patients","volume":"16","author":"Lehto","year":"2005","journal-title":"Ann. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.bjps.2005.01.010","article-title":"Psychological distress surrounding diagnosis of malignant and nonmalignant skin lesions at a pigmented lesion clinic","volume":"59","author":"Harcourt","year":"2006","journal-title":"J. Plast. Reconstr. Aesthet. Surg."},{"key":"ref_30","unstructured":"Krebsregister Schleswig-Holstein Projekte: Deutsche Krebshilfe\u2014OVIS Home Page. www.krebsregister-sh.de (10 May 2011)."},{"key":"ref_31","unstructured":"Fayers, P., Aaronson, N., Bjordal, K., Groenvold, M., Curran, D., and Bottomley, A. (1999). EORTC QLQ-C30 Scoring Manual, EORTC Quality of Life Study Group."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0959-8049(00)00447-0","article-title":"Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population","volume":"37","author":"Schwarz","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","article-title":"Interpreting the significance of changes in health-related quality-of-life scores","volume":"16","author":"Osoba","year":"1998","journal-title":"J. Clin.Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/3\/2\/2316\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:56:03Z","timestamp":1760219763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/3\/2\/2316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,11]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2011,6]]}},"alternative-id":["cancers3022316"],"URL":"https:\/\/doi.org\/10.3390\/cancers3022316","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,11]]}}}